Joint Action

On this week's special episode hear from experts in weight loss and osteoarthritis, including content from:

• Stephen Messier - Losing weight and osteoarthritis– why and how? (Season 1, Episode 4)
• Rosie Venman - Implementing dietary change (Season 1, Episode 20)

Stephen Messier has been at Wake Forest University for 36 years. He is the Director of the J.B. Snow Biomechanics Laboratory and teaches undergraduate biomechanics and human gross anatomy as well as graduate biomechanics. Dr. Messier has 26 years of clinical trial experience concerning osteoarthritis (OA) of the knee; his team of clinicians and researchers are recognized for their research regarding the effects of weight loss and exercise upon knee OA pain, function, strength, and gait biomechanics.

Rosie Venman is a clinical Dietitian working at Royal North Shore Hospital. Rosie received her Bachelor’s degree in Food Science and Human Nutrition from the University of Newcastle and a Masters in Nutrition and Dietetics from Sydney University. At Royal North Shore Hospital she has been working as the Osteoarthritis Chronic Care Program Dietitian for the last 4 years and has a keen interest in improving weight loss outcomes for this patient group.

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

Hosted on Acast. See acast.com/privacy for more information.

On this week's episode of Joint Action, learn more about the benefits of exercise, including the types of exercise recommended and how a health professional can help you get started.

We will hear from experts:

• Kim Bennell (Season 1, Episode 6)
• Matt Williams (Season 1, Episode 3)

Prof Kim Bennell (PhD, BAppSci (physio)) is a research physiotherapist and her current positions include Professor and Director of the Centre for Health, Exercise and Sports Medicine (CHESM), in Physiotherapy at the School of Health Sciences, University of Melbourne, NHMRC Principal Research Fellow and Director of the NHMRC Centre of Research Excellence in Translational Research in Musculoskeletal Pain.

Matt is Senior Physiotherapist, Musculoskeletal Coordinator. Has been the Northern Sydney Local Health District (NSLHD) lead of the innovative Osteoarthritis Chronic Care Program (OACCP) since its inception in February 2012.

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Julie Leask is a social scientist and professor of public health at the University of Sydney. She and her team conduct research looking at vaccination and what people think, feel and do about it. She has a background in nursing, midwifery and a masters degree in public health. Julie lives in Sydney on Dharug country with her husband and two adult children. She also has had osteoarthritis of her knees for three decades. On this week's episode of Joint Action, Julie shares her journey with us.

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

On this week's special episode, we will hear from experts in arthroscopy and surgery including content from:

• Peter Choong and Michelle Dowsey (Season 1, Episode 7)
• Gillian Hawker (Season 4, Episode 8)

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Professor Christopher Little is director of the Raymond Purves Bone and Joint Research Labs at the Kolling Institute of Medical Research at Royal North Shore Hospital, Australia. Chris is a qualified Veterinarian with specialist surgery training and ACVS certification. Chris's research interests focus on defining the biochemical and molecular mechanisms of joint pathology in OA, and tendon and intervertebral disc degeneration, and are based on the belief that it is only though a better understanding the mechanisms that drive the initiation and progression of these diseases that new therapies can be developed. Chris is recognized internationally for his expertise in the development and use of animal models of bone and joint disease.

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

On this week's special episode, we will hear from experts in arthroscopy and surgery including content from:

• Chris Vertullo and Teppo Järvinen - Should I have an arthroscopy for my knee arthritis? (Season 1, Episode 9)
• Howard Luks - Do you really need surgery for your knee osteoarthritis? (Season 2, Episode 20)
• Teppo Järvinen - Arthroscopy, past time to stop the harm (Season 4, Episode 4)

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

The prevalence of osteoarthritis is increasing as are rates of overweight and obesity. Overweight and obesity are both important risk factors for the onset and progression of knee osteoarthritis.

Weight loss is an effective treatment for osteoarthritis and has been shown to reduce pain and improve function – but what about structural changes? On this week’s podcast, Zübeyir Salis joins us to discuss this important topic.

RESOURCES

• Association of Decrease in Body Mass Index With Reduced Incidence and Progression of the Structural Defects of Knee Osteoarthritis: A Prospective Multi-Cohort Study

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Osteoarthritis (OA) is the most common form of arthritis. There are currently no effective disease-modifying treatments available to slow or reverse the progression of OA. Drugs such as metformin, which is commonly used to treat type 2 diabetes are generally safe and low cost. Research has been shown that metformin has anti-inflammatory and pro-weight loss effects, suggesting that the use of metformin may be useful in the treatment or prevention of OA. Dr Matthew Baker joins us on this week's episode of Joint Action to discuss this important topic.

Dr. Matthew Baker is the Clinical Chief in the Division of Immunology and Rheumatology at Stanford University. He received his bachelor's degree from Pomona College, his medical degree from Harvard Medical School, and his master's degree in Epidemiology and Clinical Research from Stanford University. He completed his Internal Medicine residency at the Massachusetts General Hospital and his Rheumatology fellowship at Stanford University. Dr. Baker has established a clinical research program that is focused on clinical trials, epidemiological studies, and bench-to-bedside translational research. He has designed and led investigator-initiated and industry sponsored clinical trials with a focus on sarcoidosis, IgG4-related disease, and rheumatoid arthritis. In addition, he is the Co-Director of the Stanford Multidisciplinary Sarcoidosis Program and collaborates with other team members to advance sarcoidosis clinical care and research.

RESOURCES

• Development of Osteoarthritis in Adults With Type 2 Diabetes Treated With Metformin vs a Sulfonylurea
• Increased risk of osteoarthritis in patients with atopic disease

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

Viscosupplementation is a procedure that involves injections of hyaluronic acid, most commonly into the knee joint. In the United States, one in every seven people receive a hyaluronic acid injection as first line treatment for their knee osteoarthritis. However, the effectiveness and safety of viscosupplementation has remained controversial. On this week’s episode of Joint Action, we are joined by Bruno da Costa to discuss viscosupplementation, their effectiveness and safety.

Dr. Bruno R. da Costa is Deputy Director of Trial Methodology Program at Nuffield Department of Population Health, University of Oxford, and Associate Professor of Clinical Epidemiology at the Institute of Health Policy, Management and Evaluation, University of Toronto. He has a Ph.D. in Clinical Epidemiology and Biostatistics from the University of Bern in Switzerland, a M.Sc. in Medical Statistics from the University of Leicester in the UK, and a M.Sc. in Physical Therapy from the University of Alberta in Canada. Dr. da Costa is considered to be an influential scientist in the field of musculoskeletal and cardiovascular disease and methodological research on comparative effectiveness. He has co-authored over 100 scholarly peer-reviewed publications, which have been published in prominent peer-reviewed scientific journals such as The New England Journal of Medicine, The Lancet, Journal of the American Medical Association (JAMA), and The BMJ.

RESOURCES

• Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.

On this week's special episode, we will hear from experts in pain including content from:

• Jason McDougall (Season 1, Episode 1)
• Anne-Marie Malfait (Season 2, Episode 14)
• Lisa Carlesso (Season 3, Episode 7)
• Tasha Stanton (Season 3, Episode 19)

CONNECT WITH US

• Twitter: @ProfDavidHunter @jointactionorg
• Email: [email protected]
• Website: www.jointaction.info/podcast

If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review!

Hosted on Acast. See acast.com/privacy for more information.